Uniform Multidrug Therapy Regimen for Leprosy Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

859

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2016

Conditions
Leprosy
Interventions
DRUG

PB 6 doses - Rifampicin and Dapsone

"Adult: 6 doses;~1 monthly supervised dose: 600 mg Rifampicin + 100 mg Dapsone; 27 days: p/day - 100 mg Dapsone;~Children: 6 doses;~1 monthly supervised dose: 450 mg Rifampicin + 50 mg Dapsone; 27 days: p/day - 50 mg Dapsone"

DRUG

PB 6 doses - Rifampicin, Clofazimine and Dapsone

"Adult: 6 doses;~1 monthly supervised dose: 600 mg Rifampicin + 300 mg Clofazimine + 100 mg Dapsone; 27 days: p/day - 100 mg Dapsone + 50 mg Clofazimine;~Children: 6 doses;~1 monthly supervised dose: Rifampicin 450 mg + 150 mg Clofazimine + 50 mg Dapsone; 27 days: p/day - 50 mg Dapsone + 25 mg Clofazimine"

DRUG

MB 12 doses - Rifampicin, Clofazimine and Dapsone

"Adult: 12 doses;~1 monthly supervised dose: 600 mg Rifampicin + 300 mg Clofazimine + 100 mg Dapsone; 27 days: p/day - 100 mg Dapsone + 50 mg Clofazimine;~Children: 12 doses;~1 monthly supervised dose: Rifampicin 450 mg + 150 mg Clofazimine + 50 mg Dapsone; 27 days: p/day - 50 mg Dapsone + 25 mg Clofazimine"

DRUG

MB 6 doses - Rifampicin, Clofazimine and Dapsone

"Adult: 6 doses~1 monthly supervised dose: 600 mg Rifampicin + 300 mg Clofazimine + 100 mg Dapsone; 27 days: p/day - 100 mg Dapsone + 50 mg Clofazimine~Children: 6 doses~1 monthly supervised dose: Rifampicin 450 mg + 150 mg Clofazimine + 50 mg Dapsone; 27 days: p/day - 50 mg Dapsone + 25 mg Clofazimine"

Trial Locations (2)

69.065-130

Centro de Referência Nacional Alfredo da Matta - FUAM, Manaus

60.101-035

Centro de Referência Nacional Dona Libânia - CDERM, Fortaleza

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

Ministry of Science and Technology, Brazil

OTHER

collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

Fundação Alfredo da Matta, Manaus, Brazil

UNKNOWN

collaborator

Instituto de Dermatologia Dona Libania, Fortaleza, Brazil

UNKNOWN

lead

University of Brasilia

OTHER

NCT00669643 - Uniform Multidrug Therapy Regimen for Leprosy Patients | Biotech Hunter | Biotech Hunter